NLS Pharmaceutics AG (NLSP) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.88

About NLS Pharmaceutics AG

NLS Pharmaceutics AG is a biopharmaceutical company headquartered in Stans, Switzerland, dedicated to the innovative discovery and development of drug therapies for rare and complex central nervous system (CNS) disorders. The company’s robust pipeline of novel therapeutics aims to meet significant unmet medical needs, utilizing proprietary technologies and extensive research initiatives. With a strong commitment to enhancing patient outcomes, NLS Pharmaceutics is poised to establish itself as...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for NLS Pharmaceutics AG and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does NLSP pay dividends?

NLS Pharmaceutics AG (NLSP) does not currently pay a regular dividend.